1. Home
  2. KELYA vs CERS Comparison

KELYA vs CERS Comparison

Compare KELYA & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

HOLD

Current Price

$8.72

Market Cap

302.8M

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$1.69

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYA
CERS
Founded
1946
1991
Country
United States
United States
Employees
4900
N/A
Industry
Professional Services
EDP Services
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
302.8M
276.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
KELYA
CERS
Price
$8.72
$1.69
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
403.2K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.46%
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
N/A
$20.00
Revenue Next Year
$4.60
$9.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$7.98
$1.12
52 Week High
$14.94
$2.96

Technical Indicators

Market Signals
Indicator
KELYA
CERS
Relative Strength Index (RSI) 32.69 30.71
Support Level $8.42 $1.37
Resistance Level $8.90 $2.26
Average True Range (ATR) 0.29 0.16
MACD -0.08 -0.08
Stochastic Oscillator 6.72 5.66

Price Performance

Historical Comparison
KELYA
CERS

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: